Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo

Latest news

Life Science

Let us cooperate on precise health technologies

Oslo Cancer Cluster
November 8, 2018

International cooperation is key to fulfilling our vision of making cancer treatments more precise, and giving the patients new treatments more quickly.

Life Science

SmiLe Incubator and companies attend BIO-Europe in Copenhagen

SmiLe Incubator
November 8, 2018

SmiLe Incubator and several of the incubator companies are attending BIO-Europe November 5-7 in Copenhagen. This year the life sciences partnering conference, the largest in Europe, is being held outside the German speaking countries for the first time. It is also record-breaking in size: 4,400 attendees and 122,000 prearranged meetings.

Life Science

Nordic Rebalance launches product that relieves symptoms of IBS and ulcerative colitis

SmiLe Incubator
November 8, 2018

SmiLe company Nordic Rebalance is launching its product Refermin on November 5. Refermin is a fermented oat drink that contains beneficial fermentation products and health-promoting bacteria. The drink has been shown to have a clinical effect and relieves symptoms of IBS and ulcerative colitis. Refermin is sold online at www.refermin.se.

Finance

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2019 Annual General Meeting

InDex Pharmaceuticals
November 7, 2018

InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2019 Annual General Meeting, which will be held on Monday May 6, 2019. The responsibility of the Nomination Committee is to present to the 2019 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.

Life Science

AbbVie Receives European Commission Approval of VENCLYXTO® (venetoclax) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

AbbVie
November 2, 2018

‍The approval is based on the MURANO Phase 3 clinical trial, in which VENCLYXTO® plus rituximab reduced the risk of disease progression or death by 83 percent and overall survival was prolonged compared to bendamustine in combination with rituximab, a standard of care chemoimmunotherapy regimen

Life Science

Meet us at BioEurope

Redoxis
October 29, 2018

Redoxis will be represented at BioEurope taking place in Copenhagen 5-7th of November.

Life Science

Medicon Valley - a stepping stone to life science in the Nordics

Medicon Valley Alliance
October 26, 2018

The new Medicon Valley special edition of Affärstidningen Näringsliv titled ” Time to Unite – A Greater Medicon Valley” has just been published online here.

Pharma

Cardiovascular safety data added to Saxenda® label

Novo Nordisk
October 25, 2018

Saxenda® is the first and only FDA-approved medicine in a pen indicated to help adults lose weight and keep it off

Finance

InDex Pharmaceuticals carries out a directed share issue of approximately SEK 37.5 million

InDex Pharmaceuticals
October 25, 2018

The board of directors of InDex Pharmaceuticals Holding AB (publ) (the “Company” or “InDex”) has, with support from the authorization granted by the annual general meeting on May 24, 2018, resolved on a directed share issue of 6,252,842 shares to a small group of investors.

Life Science

Gedea starts clinical study

SmiLe Incubator
October 23, 2018

Swedish Medical Products Agency and Ethics Committee have announced that they approve Gedea’s first clinical study. The study is an important step prior to CE marking ofpHyph, which is a completely new type of treatment for vaginal infection. pHyph is expected to be able to treat both vaginal fungal infections and bacterial vaginosis and may become the first product on the market for treatment of both types of infection.

Pharma

Positive Phase 2b Data for AbbVie's Upadacitinib Show Significant Induction of Clinical Remission and Response in Patients with Ulcerative Colitis

AbbVie
October 23, 2018

‍In U-ACHIEVE, upadacitinib (15/30/45 mg, once daily) met the primary endpoint of clinical remission (per Adapted Mayo Score) and all ranked secondary endpoints, including endoscopic improvement, clinical remission (per Full Mayo Score) and clinical response, in patients with moderately to severely active ulcerative colitis

Pharma

InDex Pharmaceuticals publishes post-hoc analysis of the COLLECT study

InDex Pharmaceuticals
October 19, 2018

InDex Pharmaceuticals Holding AB (publ) today announced the publication of a post-hoc analysis of COLLECT study data. COLLECT was a clinical study of the Toll-like receptor 9 (TLR9) agonist cobitolimod, a first-in-class treatment for patients with moderate to severe ulcerative colitis (UC).

Life Science

– An idea needs to attract investors

Oslo Cancer Cluster
October 18, 2018

Meet Thomas Andersson, our new Senior Advisor Business Development. How could he be of help to your startup company?

Read more articles

In focus

Umeå Biotech Incubator
SmiLe Incubator
ALK

Featured items

State of Medicon Valley 2018
State of Medicon Valley 2018
Medicon Valley Alliance
T-cells and the Nobel Price
T-cells and the Nobel Price
Oslo Cancer Cluster
The Life Science Industry – crucial for Sweden!
The Life Science Industry – crucial for Sweden!
Medicon Valley Alliance
Vessela Kristensen Receives Cancer Research Award
Vessela Kristensen Receives Cancer Research Award
Oslo Cancer Cluster
Strong presence of Nordic skills and innovations in life science at Arab Health 2018
Strong presence of Nordic skills and innovations in life science at Arab Health 2018
Global Pharma Consulting

Companies

Ideon Science Park

Medicon Valley Alliance

Medicon Village AB

Novo Nordisk

Oslo Cancer Cluster

SwedenBIO

Browse all the companies

Events

NLSDays
NLSDays
September 10, 2018
-
September 12, 2018
Stockholm Waterfront, Sweden
BIO-Europe
BIO-Europe
November 5, 2018
-
November 7, 2018
CityCube Berlin, Berlin, Germany
Medica 2018
Medica 2018
November 12, 2018
-
November 15, 2018
Düsseldorf, Germany - Exhibition
Arab Health
Arab Health
January 28, 2019
-
January 31, 2019
Dubai International Convention and Exhibition Centre
BIO-Europe Spring
BIO-Europe Spring
March 25, 2019
-
March 29, 2019
Vienna, Austria
Analytica
Analytica
March 31, 2020
-
April 3, 2020
Messe München
NLSDays
September 10, 2018
-
September 12, 2018
Stockholm Waterfront, Sweden
BIO-Europe
November 5, 2018
-
November 7, 2018
CityCube Berlin, Berlin, Germany
Medica 2018
November 12, 2018
-
November 15, 2018
Düsseldorf, Germany - Exhibition
Arab Health
January 28, 2019
-
January 31, 2019
Dubai International Convention and Exhibition Centre
BIO-Europe Spring
March 25, 2019
-
March 29, 2019
Vienna, Austria
Analytica
March 31, 2020
-
April 3, 2020
Messe München

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2017